Vyndaqel 61 mg, Weichkapseln

7680675180011 CH-67518 Weichkapseln
Vyndaqel 61 mg, Weichkapseln
Vyndaqel 61 mg, Weichkapseln
Vyndaqel 61 mg, Weichkapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
61.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 9031.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2021

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
67518
Drug name
Vyndaqel 61 mg, Weichkapseln
Galenic form
KAPWE
ATC Code
N07XX08
Authorization status
Z
Dispensing category
B
First authorization
05/03/2020
Authorization expiration date
31/12/9999
IT Number
01.99.0.
Domain
Human medicine
Field of application
Behandlung der Transthyretin-Amyloidose bei erwachsenen Patienten mit Wildtyp- oder hereditärer Kardiomyopathie

Package details

Description (FR)
VYNDAQEL caps moll 61 mg 30 pce
Description (DE)
VYNDAQEL Weichkaps 61 mg 30 Stk
Market launch
05/03/2020
Narcotic (BTM)
No